Societies Release HF Guideline Focused Update

The ACC, along with the American Heart Association (AHA) and the Heart Failure Society of America (HFSA), have released a focused update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. The focused update was published April 28 in the Journal of the American College of Cardiology. The document is the second of a two-part focused update to the 2013 heart failure (HF) guideline. Part one, published in May 2016, introduced guidance on new pharmacological therapies for patients in Stage C HF with reduced ejection fraction. This second part of the focused update incorporates the guidance from part one, and includes a new figure that puts the new HF pharmacotherapies in context with previous therapies, as well as a revision to the sections on biomarkers, including recommendations for the prevention, diagnosis and prevention or added risk stratification of HF; updates on HF with preserved ejection fraction; new data on important comorbidities including sleep apnea, anemia and hypertension; and new insights regarding the prevention of HF. Read more on